• 1. Evidence of pre-micellar aggregates in aqueous solution of amphiphilic PDMS–PEO block copolymer?
  Domenico Lombardo,Gianmarco Munaò,Pietro Calandra,Luigi Pasqua,Maria Teresa Caccamo Phys. Chem. Chem. Phys., 2019,21, 11983-11991
• 2. Evolutionary approaches in protein engineering towards biomaterial construction
  Brindha J.,Balamurali M. M.,Kaushik Chanda RSC Adv., 2019,9, 34720-34734
• 3. Evolved polymerases facilitate selection of fully 2′-OMe-modified aptamers?
  Zhixia Liu,Tingjian Chen,Floyd E. Romesberg Chem. Sci., 2017,8, 8179-8182
• 4. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789
• 5. Enantiomerically pure 1,3,2-dioxaborolanes: new reagents for the hydroboration of alkynes
  Chem. Commun., 1998, 2651-2652

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Sulfanilides
• Solvents and Organic Chemicals Organic Compounds Amines/Sulfonamides
• Solvents and Organic Chemicals Organic Compounds

Research Brief on 4-(Methylsulfonylamino)benzylamine hydrochloride (CAS: 128263-66-1) in Chemical Biology and Pharmaceutical Applications

4-(Methylsulfonylamino)benzylamine hydrochloride (CAS: 128263-66-1) is a chemically synthesized compound that has garnered significant attention in recent years due to its potential applications in medicinal chemistry and drug discovery. This research brief aims to provide an updated overview of the latest findings related to this compound, focusing on its synthesis, biological activities, and therapeutic potential. The compound's unique structural features, including the methylsulfonylamino and benzylamine moieties, make it a promising candidate for the development of novel pharmaceutical agents.

Recent studies have explored the synthesis and optimization of 4-(Methylsulfonylamino)benzylamine hydrochloride, with particular emphasis on improving yield and purity. Advanced techniques such as high-performance liquid chromatography (HPLC) and nuclear magnetic resonance (NMR) spectroscopy have been employed to characterize the compound and ensure its structural integrity. These efforts are critical for establishing a reliable supply chain for further pharmacological evaluations.

In terms of biological activity, preliminary research indicates that 4-(Methylsulfonylamino)benzylamine hydrochloride exhibits notable interactions with various enzymatic targets. For instance, it has shown inhibitory effects on certain kinases involved in inflammatory pathways, suggesting potential applications in treating autoimmune diseases. Additionally, its ability to modulate receptor activity in the central nervous system (CNS) has sparked interest in its use for neurological disorders, although further in vivo studies are required to validate these findings.

One of the most promising aspects of this compound is its role as a building block in the synthesis of more complex molecules. Researchers have successfully incorporated 4-(Methylsulfonylamino)benzylamine hydrochloride into the design of novel small-molecule inhibitors and probes, leveraging its chemical versatility. This approach has opened new avenues for drug discovery, particularly in targeting hard-to-treat diseases such as cancer and neurodegenerative conditions.

Despite these advancements, challenges remain in the development and application of 4-(Methylsulfonylamino)benzylamine hydrochloride. Issues such as solubility, bioavailability, and potential toxicity need to be addressed through systematic structure-activity relationship (SAR) studies. Collaborative efforts between academia and industry are essential to overcome these hurdles and translate laboratory findings into clinically viable therapies.

In conclusion, 4-(Methylsulfonylamino)benzylamine hydrochloride (CAS: 128263-66-1) represents a compound of significant interest in the field of chemical biology and pharmaceutical research. Its multifaceted applications, from enzyme inhibition to drug design, highlight its potential as a valuable tool in modern medicine. Ongoing and future studies will undoubtedly shed more light on its mechanisms of action and therapeutic utility, paving the way for innovative treatments.

• 100632-99-3(Methanesulfonamide, N-[4-[(diethylamino)methyl]phenyl]-)
• 114100-09-3(N-3-(Aminomethyl)phenylmethanesulfonamide)
• 66236-08-6(Methanesulfonamide, N-(3,5-dimethylphenyl)-)
• 1154669-37-0(N-[3-(Methylaminomethyl)phenyl]methanesulfonamide)
• 1199775-70-6(N-[4-(Methylaminomethyl)phenyl]methanesulfonamide)
• 681810-37-7(Methanesulfonamide, N-[4-[(hydroxyamino)methyl]phenyl]-)
• 515153-84-1(2-(Methylsulfonylamino)benzylamine)
• 129872-50-0(Methanesulfonamide,N-[4-(aminomethyl)phenyl]-)
• 1170256-90-2(2-(Methylsulfonylamino)benzylamine hydrochloride)
• 238428-26-7(3-(Methylsulfonylamino)benzylamine hydrochloride)